DERMIK LABS BOOSTING PRESENCE IN OTC SKIN CARE MARKET
This article was originally published in The Tan Sheet
DERMIK LABS BOOSTING PRESENCE IN OTC SKIN CARE MARKET via a joint venture with Colombes, France-based RoC S.A. The French firm manufactures skin care products, specializing in hypo-allergenic brands sold in European drugstores. Under the agreement, Dermik will distribute and market a line of skin care products including moisturizers, cleansers and sun protection items in the U.S. and Puerto Rico. RoC will manufacture the products in Paris. The products are "hypo-allergenic, perfume-free and do not cause acne," according to the Rhone-Poulenc Rorer division. Dermik currently markets prescription dermatologicals such as Benzamycin (erythromycin/benzoyl peroxide), Florone, and Psorcon (diflorasone diacetate). Dermik also sells OTC and prescription hydrocortisone products under the Hytone name. "Since Dermik is committed to dermatology, the heritage of RoC was important to us . . . Their historical attention to the needs of the dermatologist is a perfect complement to the Dermik mission," RPR Dermatologicals General Manager and VP Thomas Bigger said. RoC S.A. was founded in 1987 by Jean-Charles Lissarrague, a pharmacist. The firm markets its products in over 50 countries worldwide, selling about 30 mil. units.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Sign in to continue reading.
Need a specific report?
1000+ reports available
New to Pink Sheet?
Start a free trial today!
Register for our free email digests: